Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use RABEPRAZOLE SODIUM DELAYED-RELEASE CAPSULES safely and effectively. See full prescribing information for RABEPRAZOLE SODIUM DELAYED-RELEASE CAPSULES. Rabeprazole Sodium Delayed-Release Capsules (Sprinkle), for oral useInitial U.S. Approval: 1999
Medication labelWhy this: Advisory · dailymed-prescription
Rabeprazole sodium delayed-release capsules are indicated for treatment of Gastroesophageal Reflux Disease (GERD) in pediatric patients 1 to 11 years of age for up to 12 weeks.
- generic_name
- rabeprazole sodium
- product_names
- rabeprazole sodium
- ndc
- 72834-210, 72834-210-30
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en